Login/Sign Up
MRP ₹864
(Inclusive of all Taxes)
₹129.6 Cashback (15%)
MOOSTIN 40MG TABLET is used to treat Brain Tumors and Hodgkin's Disease. It contains Lomustine, which belongs to the alkylating agent’s class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. Common side effects of this medication may include nausea, vomiting, headache, visual disturbances, blindness, disorientation, lack of energy, loss of control, and difficulty talking.
Provide Delivery Location
About MOOSTIN 40MG TABLET
MOOSTIN 40MG TABLET is an anti-cancer medicine used in the treatment of brain tumors. A tumor is defined as the formation of solid mass tissue due to the abnormal growth of cells. MOOSTIN 40MG TABLET is used in the treatment of primary and metastatic brain tumors along with appropriate surgical or radiotherapeutic procedures. A brain tumor is a serious condition where the cells (cancerous or non-cancerous) grow abnormally in the brain. MOOSTIN 40MG TABLET is also used in the treatment of Hodgkin’s Disease when used in combination with other chemotherapies.
MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
MOOSTIN 40MG TABLET may cause certain side effects, such as nausea, vomiting, headache, visual disturbances, blindness, disorientation, lack of energy, loss of control, and difficulty talking. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor. MOOSTIN 40MG TABLET should be taken as prescribed by your doctor. Do not take more than the recommended dose of medicine.
MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. This medicine is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. It is unknown whether MOOSTIN 40MG TABLET is suitable for children's use. Hence, please consult your doctor or paediatrician for information on children's use. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should only be taken once in 6 weeks as taking more than the recommended dose can cause serious life-threatening problems. Hence, talk to your doctor or pharmacist before starting the treatment.
Uses of MOOSTIN 40MG TABLET
Have a query?
Directions for Use
Medicinal Benefits
MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.
How MOOSTIN 40MG TABLET Works
Storage
What if I have taken an overdose of MOOSTIN 40MG TABLET
Drug Warnings
MOOSTIN 40MG TABLET should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. This medicine can cause a severe decrease in the number of blood cells in your bone marrow. A decrease in the number of blood cells in your body may cause certain symptoms and increase the risk of developing a serious infection or bleeding. Before administration, inform your doctor if you have liver/kidney disease, blood disorders, or respiratory conditions. MOOSTIN 40MG TABLET may cause pulmonary toxicity, delayed myelosuppression, pulmonary fibrosis, secondary malignancies, nephrotoxicity, and hepatotoxicity in some patients. Hence, careful monitoring should be done during the entire treatment. MOOSTIN 40MG TABLET is known to cause embryo-fetal harm in pregnant women. Hence, inform your doctor if you are pregnant or are planning to become pregnant. Breastfeeding should be discontinued in nursing mothers during the treatment. MOOSTIN 40MG TABLET should be given in children only if prescribed by the paediatrician. Avoid alcohol consumption and smoking, as it can lead to serious adverse effects. MOOSTIN 40MG TABLET may cause visual disturbances as a side effect. Hence, avoid driving vehicles or operating machines until you can see clearly. MOOSTIN 40MG TABLET should be taken once in 6 weeks only. Hence, talk to your doctor or pharmacist before starting the treatment.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Unsafe
Avoid alcohol consumption while on treatment with MOOSTIN 40MG TABLET to prevent serious adverse effects.
Pregnancy
Unsafe
MOOSTIN 40MG TABLET is not recommended for use in pregnancy as it may harm your fetus. If you are pregnant or planning pregnancy, inform your doctor before taking MOOSTIN 40MG TABLET.
Breast Feeding
Unsafe
Avoid breastfeeding your child while on treatment with MOOSTIN 40MG TABLET as it causes serious side effects to the baby.
Driving
Unsafe
MOOSTIN 40MG TABLET may cause visual disturbances as a side effect. Avoid driving vehicles or operating machines until you are alert.
Liver
Caution
MOOSTIN 40MG TABLET may cause hepatotoxicity. If you have a pre-existing or a history of liver disease, inform your doctor before taking MOOSTIN 40MG TABLET. Your liver function should be monitored carefully before, during and after the treatment with MOOSTIN 40MG TABLET.
Kidney
Caution
MOOSTIN 40MG TABLET and its metabolites are known to be largely eliminated via the kidney, and the risk of adverse responses to this medicine may be higher in patients with impaired renal function. It may cause nephrotoxicity with progressive renal failure and a decrease in kidney size. Hence, if you have a pre-existing or a history of kidney disease, inform your doctor before taking MOOSTIN 40MG TABLET.
Children
Caution
Please consult a doctor. Your child's doctor may recommend this medicine based on the age, body weight and disease condition of your child.
MOOSTIN 40MG TABLET is used to treat Brain Tumors and Hodgkin's Disease.
MOOSTIN 40MG TABLET contains Lomustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis.
MOOSTIN 40MG TABLET may cause or worsen pulmonary toxicity, myelosuppression, nephrotoxicity and hepatotoxicity. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any adverse effects/interactions.
MOOSTIN 40MG TABLET is effective in treating brain tumours and Hodgkin's lymphoma (a rare type of blood cancer that affects the lymphatic system). However, its effectiveness can vary depending on the type and stage of cancer, how the body responds to the medication, and whether it is used alone or in combination with other anti-cancer drugs. Always follow your doctor's instructions, as proper dosing and monitoring are crucial for maximizing its effectiveness.
MOOSTIN 40MG TABLET does not work immediately. It may take several weeks or months to see the full effect of the treatment as the drug gradually slows the growth of cancer cells. Your doctor will monitor your progress and adjust your treatment plan accordingly.
MOOSTIN 40MG TABLET has a long half-life, typically 16 to 48 hours, meaning it can remain in your body for several days. However, its effects can last longer, as it works in the body for weeks.
If you miss a dose of MOOSTIN 40MG TABLET, take it as soon as you remember unless it is almost time for your next dose. In that case, skip the missed dose and take your next dose at the usual time. Do not take two doses at once to make up for a missed dose. Always follow your doctor's instructions for dosing.
MOOSTIN 40MG TABLET may cause common side effects, such as nausea, vomiting, headache, visual disturbances, blindness, disorientation, lack of energy, loss of control, and difficulty talking in some individuals. These side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Before taking MOOSTIN 40MG TABLET, it's important to share your medical history and current medications with your doctor. If you have any allergies, liver or kidney problems, or breathing issues, be sure to let them know. MOOSTIN 40MG TABLET can lower your blood count, making you more prone to infections or bleeding, and may cause vision problems, so be careful when driving or operating machinery. Additionally, if you're pregnant or breastfeeding, inform your doctor, and children should only take MOOSTIN 40MG TABLET under a paediatrician's care. Typically taken every 6 weeks, be sure to consult your doctor or pharmacist before starting treatment.
Yes, women can use MOOSTIN 40MG TABLET only if recommended by a doctor. MOOSTIN 40MG TABLET is a chemotherapy drug, and its use may require special considerations for women, particularly those who are pregnant, breastfeeding, or planning to become pregnant. This is because it can harm the developing foetus or be passed to the baby through breast milk. Always consult with your doctor before using MOOSTIN 40MG TABLET. Your doctor will evaluate the benefits and risks before prescribing it and may monitor you for any side effects.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd